US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease

Periprocedural results

David Fiorella, Elad I. Levy, Aquilla S. Turk, Felipe C. Albuquerque, David B. Niemann, Beverly Aagaard-Kienitz, Ricardo A. Hanel, Henry Woo, Peter A. Rasmussen, L. Nelson Hopkins, Thomas J. Masaryk, Cameron McDougall

Research output: Contribution to journalArticle

Abstract

BACKGROUND AND PURPOSE - The current report details our initial periprocedural experience with Wingspan (Boston Scientific/Target), the first self-expanding stent system designed for the treatment of intracranial atheromatous disease. METHODS - All patients undergoing angioplasty and stenting with the Gateway balloon-Wingspan stent system were prospectively tracked. RESULTS - During a 9-month period, treatment with the stent system was attempted in 78 patients (average age, 63.6 years; 33 women) with 82 intracranial atheromatous lesions, of which 54 were ≥70% stenotic. Eighty-one of 82 lesions were successfully stented (98.8%) during the first treatment session. In 1 case, the stent could not be delivered across the lesion; the patient was treated solely with angioplasty and stented at a later date. Lesions treated involved the internal carotid (n=32; 8 petrous, 10 cavernous, 11 supraclinoid segment, 3 terminus), vertebral (n=14; V4 segment), basilar (n=14), and middle cerebral (n=22) arteries. Mean±SD pretreatment stenosis was 74.6±13.9%, improving to 43.5±18.1% after balloon angioplasty and to 27.2±16.7% after stent placement. Of the 82 lesions treated, there were 5 (6.1%) major periprocedural neurological complications, 4 of which ultimately led to patient death within 30 days of the procedure. CONCLUSIONS - Angioplasty and stenting for symptomatic intracranial atheromatous disease can be performed with the Gateway balloon-Wingspan stent system with a high rate of technical success and acceptable periprocedural morbidity. Our initial experience indicates that this procedure represents a viable treatment option for this patient population.

Original languageEnglish (US)
Pages (from-to)881-887
Number of pages7
JournalStroke
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

Stents
Angioplasty
Therapeutics
Balloon Angioplasty
Pathologic Constriction
Arteries
Morbidity
Population

Keywords

  • Angioplasty
  • Intracranial atheromatous disease
  • Stenting
  • Wingspan

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease : Periprocedural results. / Fiorella, David; Levy, Elad I.; Turk, Aquilla S.; Albuquerque, Felipe C.; Niemann, David B.; Aagaard-Kienitz, Beverly; Hanel, Ricardo A.; Woo, Henry; Rasmussen, Peter A.; Hopkins, L. Nelson; Masaryk, Thomas J.; McDougall, Cameron.

In: Stroke, Vol. 38, No. 3, 01.03.2007, p. 881-887.

Research output: Contribution to journalArticle

Fiorella, D, Levy, EI, Turk, AS, Albuquerque, FC, Niemann, DB, Aagaard-Kienitz, B, Hanel, RA, Woo, H, Rasmussen, PA, Hopkins, LN, Masaryk, TJ & McDougall, C 2007, 'US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results', Stroke, vol. 38, no. 3, pp. 881-887. https://doi.org/10.1161/01.STR.0000257963.65728.e8
Fiorella, David ; Levy, Elad I. ; Turk, Aquilla S. ; Albuquerque, Felipe C. ; Niemann, David B. ; Aagaard-Kienitz, Beverly ; Hanel, Ricardo A. ; Woo, Henry ; Rasmussen, Peter A. ; Hopkins, L. Nelson ; Masaryk, Thomas J. ; McDougall, Cameron. / US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease : Periprocedural results. In: Stroke. 2007 ; Vol. 38, No. 3. pp. 881-887.
@article{7f29551299a946599005c534a81b12bc,
title = "US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results",
abstract = "BACKGROUND AND PURPOSE - The current report details our initial periprocedural experience with Wingspan (Boston Scientific/Target), the first self-expanding stent system designed for the treatment of intracranial atheromatous disease. METHODS - All patients undergoing angioplasty and stenting with the Gateway balloon-Wingspan stent system were prospectively tracked. RESULTS - During a 9-month period, treatment with the stent system was attempted in 78 patients (average age, 63.6 years; 33 women) with 82 intracranial atheromatous lesions, of which 54 were ≥70{\%} stenotic. Eighty-one of 82 lesions were successfully stented (98.8{\%}) during the first treatment session. In 1 case, the stent could not be delivered across the lesion; the patient was treated solely with angioplasty and stented at a later date. Lesions treated involved the internal carotid (n=32; 8 petrous, 10 cavernous, 11 supraclinoid segment, 3 terminus), vertebral (n=14; V4 segment), basilar (n=14), and middle cerebral (n=22) arteries. Mean±SD pretreatment stenosis was 74.6±13.9{\%}, improving to 43.5±18.1{\%} after balloon angioplasty and to 27.2±16.7{\%} after stent placement. Of the 82 lesions treated, there were 5 (6.1{\%}) major periprocedural neurological complications, 4 of which ultimately led to patient death within 30 days of the procedure. CONCLUSIONS - Angioplasty and stenting for symptomatic intracranial atheromatous disease can be performed with the Gateway balloon-Wingspan stent system with a high rate of technical success and acceptable periprocedural morbidity. Our initial experience indicates that this procedure represents a viable treatment option for this patient population.",
keywords = "Angioplasty, Intracranial atheromatous disease, Stenting, Wingspan",
author = "David Fiorella and Levy, {Elad I.} and Turk, {Aquilla S.} and Albuquerque, {Felipe C.} and Niemann, {David B.} and Beverly Aagaard-Kienitz and Hanel, {Ricardo A.} and Henry Woo and Rasmussen, {Peter A.} and Hopkins, {L. Nelson} and Masaryk, {Thomas J.} and Cameron McDougall",
year = "2007",
month = "3",
day = "1",
doi = "10.1161/01.STR.0000257963.65728.e8",
language = "English (US)",
volume = "38",
pages = "881--887",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease

T2 - Periprocedural results

AU - Fiorella, David

AU - Levy, Elad I.

AU - Turk, Aquilla S.

AU - Albuquerque, Felipe C.

AU - Niemann, David B.

AU - Aagaard-Kienitz, Beverly

AU - Hanel, Ricardo A.

AU - Woo, Henry

AU - Rasmussen, Peter A.

AU - Hopkins, L. Nelson

AU - Masaryk, Thomas J.

AU - McDougall, Cameron

PY - 2007/3/1

Y1 - 2007/3/1

N2 - BACKGROUND AND PURPOSE - The current report details our initial periprocedural experience with Wingspan (Boston Scientific/Target), the first self-expanding stent system designed for the treatment of intracranial atheromatous disease. METHODS - All patients undergoing angioplasty and stenting with the Gateway balloon-Wingspan stent system were prospectively tracked. RESULTS - During a 9-month period, treatment with the stent system was attempted in 78 patients (average age, 63.6 years; 33 women) with 82 intracranial atheromatous lesions, of which 54 were ≥70% stenotic. Eighty-one of 82 lesions were successfully stented (98.8%) during the first treatment session. In 1 case, the stent could not be delivered across the lesion; the patient was treated solely with angioplasty and stented at a later date. Lesions treated involved the internal carotid (n=32; 8 petrous, 10 cavernous, 11 supraclinoid segment, 3 terminus), vertebral (n=14; V4 segment), basilar (n=14), and middle cerebral (n=22) arteries. Mean±SD pretreatment stenosis was 74.6±13.9%, improving to 43.5±18.1% after balloon angioplasty and to 27.2±16.7% after stent placement. Of the 82 lesions treated, there were 5 (6.1%) major periprocedural neurological complications, 4 of which ultimately led to patient death within 30 days of the procedure. CONCLUSIONS - Angioplasty and stenting for symptomatic intracranial atheromatous disease can be performed with the Gateway balloon-Wingspan stent system with a high rate of technical success and acceptable periprocedural morbidity. Our initial experience indicates that this procedure represents a viable treatment option for this patient population.

AB - BACKGROUND AND PURPOSE - The current report details our initial periprocedural experience with Wingspan (Boston Scientific/Target), the first self-expanding stent system designed for the treatment of intracranial atheromatous disease. METHODS - All patients undergoing angioplasty and stenting with the Gateway balloon-Wingspan stent system were prospectively tracked. RESULTS - During a 9-month period, treatment with the stent system was attempted in 78 patients (average age, 63.6 years; 33 women) with 82 intracranial atheromatous lesions, of which 54 were ≥70% stenotic. Eighty-one of 82 lesions were successfully stented (98.8%) during the first treatment session. In 1 case, the stent could not be delivered across the lesion; the patient was treated solely with angioplasty and stented at a later date. Lesions treated involved the internal carotid (n=32; 8 petrous, 10 cavernous, 11 supraclinoid segment, 3 terminus), vertebral (n=14; V4 segment), basilar (n=14), and middle cerebral (n=22) arteries. Mean±SD pretreatment stenosis was 74.6±13.9%, improving to 43.5±18.1% after balloon angioplasty and to 27.2±16.7% after stent placement. Of the 82 lesions treated, there were 5 (6.1%) major periprocedural neurological complications, 4 of which ultimately led to patient death within 30 days of the procedure. CONCLUSIONS - Angioplasty and stenting for symptomatic intracranial atheromatous disease can be performed with the Gateway balloon-Wingspan stent system with a high rate of technical success and acceptable periprocedural morbidity. Our initial experience indicates that this procedure represents a viable treatment option for this patient population.

KW - Angioplasty

KW - Intracranial atheromatous disease

KW - Stenting

KW - Wingspan

UR - http://www.scopus.com/inward/record.url?scp=33947498696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947498696&partnerID=8YFLogxK

U2 - 10.1161/01.STR.0000257963.65728.e8

DO - 10.1161/01.STR.0000257963.65728.e8

M3 - Article

VL - 38

SP - 881

EP - 887

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 3

ER -